Compare
PolyPid Ltd. vs Picard Medical, Inc. vs Polyrizon Ltd. vs Spectral AI, Inc.
| Latest fiscal year | PolyPid Ltd. PYPD | Picard Medical, Inc. PMI | Polyrizon Ltd. PLRZ | Spectral AI, Inc. MDAI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $4.94M | n/a | $19.65M |
| Revenue growth (YoY) | n/a | +12.5% | n/a | -33.6% |
| Gross margin | n/a | -4.1% | n/a | 45.4% |
| Operating margin | n/a | -268.4% | n/a | -43.8% |
| Net margin | n/a | -546.6% | n/a | -38.5% |
| Net income | -$34.17M | -$27.00M | -$3.33M | -$7.57M |
| EPS (Diluted) | $2.09 | n/a | $4.90 | -$0.29 |
| Operating cash flow | -$27.88M | -$15.67M | -$4.53M | -$9.92M |
| Free cash flow | -$28.09M | n/a | -$4.54M | n/a |
| Cash & equivalents | $6.40M | $7.45M | $1.31M | $15.40M |
| Total assets | $22.31M | $22.55M | $21.44M | $21.41M |
| Total liabilities | n/a | $18.76M | n/a | $27.13M |
| Shareholders' equity | $10.97M | $3.79M | $20.99M | -$5.73M |
| Return on year-end equity | -311.4% | -712.6% | -15.9% | n/a |
| Shares outstanding | 18.20M | 73.70M | 1.61M | 30.69M |
Revenue, most recent five fiscal years
| Fiscal year | PolyPid Ltd. | Picard Medical, Inc. | Polyrizon Ltd. | Spectral AI, Inc. |
|---|---|---|---|---|
| Latest | n/a | $4.94M Ended 2025-12-31 | n/a | $19.65M Ended 2025-12-31 |
| 1 year earlier | n/a | $4.39M Ended 2024-12-31 | n/a | $29.58M Ended 2024-12-31 |
| 2 years earlier | n/a | n/a | n/a | $18.06M Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | n/a | $25.37M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | n/a | n/a |